| For: | Larrubia JR, Benito-Martínez S, Miquel J, Calvino M, Sanz-de-Villalobos E, Parra-Cid T. Costimulatory molecule programmed death-1 in the cytotoxic response during chronic hepatitis C. World J Gastroenterol 2009; 15(41): 5129-5140 [PMID: 19891011 DOI: 10.3748/wjg.15.5129] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v15/i41/5129.htm |
| Number | Citing Articles |
| 1 |
Julia K. Tietze, Gail D. Sckisel, Hui-Hua Hsiao, William J. Murphy. Antigen-specific versus Antigen-nonspecific Immunotherapeutic Approaches for Human Melanoma: The Need for Integration for Optimal Efficacy?. International Reviews of Immunology 2011; 30(5-6) doi: 10.3109/08830185.2011.598977
|
| 2 |
Jil M. Jubel, Zachary R. Barbati, Christof Burger, Dieter C. Wirtz, Frank A. Schildberg. The Role of PD-1 in Acute and Chronic Infection. Frontiers in Immunology 2020; 11 doi: 10.3389/fimmu.2020.00487
|
| 3 |
Hui Wang, Ning Zhang, Rongshuang Xu, Cundong Ji, Youzhen Wei, Qing Mi. The PD-1/PD-L1 pathway and Epstein–Barr virus. European Journal of Medical Research 2025; 30(1) doi: 10.1186/s40001-025-02694-1
|
| 4 |
Stephanie F. James, Vicki Traina-Dorge, Eileen Deharo, Mary Wellish, Brent E. Palmer, Don Gilden, Ravi Mahalingam. T cells increase before zoster and PD-1 expression increases at the time of zoster in immunosuppressed nonhuman primates latently infected with simian varicella virus. Journal of NeuroVirology 2014; 20(3) doi: 10.1007/s13365-014-0237-7
|
| 5 |
Yonghui Qiu, Jiawei Liu, Xiaoyu Yang, Lei Hou, Xiaoyuan Lan, Beiyi Zhou, Qianqian Zhang, Wei Gao, Xue Dong, Shaobin Shang, Jianwei Zhou, Jue Liu. Host immune responses to porcine circovirus type 2d infection in C57BL/6 mice: lymphocyte activation, thymic T-cell dynamics, and Treg expansion. Animal Diseases 2026; 6(1) doi: 10.1186/s44149-026-00252-8
|
| 6 |
Elia Moreno-Cubero, Juan-Ramón Larrubia. Specific CD8<sup>+</sup> T cell response immunotherapy for hepatocellular carcinoma and viral hepatitis. World Journal of Gastroenterology 2016; 22(28): 6469-6483 doi: 10.3748/wjg.v22.i28.6469
|
| 7 |
Andrew Stamm, Laura Valentine, Rashaun Potts, Mary Premenko-Lanier. An intermediate dose of LCMV clone 13 causes prolonged morbidity that is maintained by CD4+ T cells. Virology 2012; 425(2) doi: 10.1016/j.virol.2012.01.005
|
| 8 |
Sheng-Wei Pan, Chin-Chung Shu, Jhong-Ru Huang, Chang-Ching Lee, Yen-Han Tseng, Jung-Jyh Hung, Po-Kuei Hsu, Nien-Jung Chen, Wei-Juin Su, Jia-Yih Feng, Yuh-Min Chen. PD-L1 Expression in Monocytes Correlates with Bacterial Burden and Treatment Outcomes in Active Pulmonary Tuberculosis. International Journal of Molecular Sciences 2022; 23(3) doi: 10.3390/ijms23031619
|
| 9 |
X. F. Wang, Y. Lei, M. Chen, C. B. Chen, H. Ren, T. D. Shi. PD‐1/PDL1 and CD28/CD80 pathways modulate natural killer T cell function to inhibit hepatitis B virus replication. Journal of Viral Hepatitis 2013; 20(s1) doi: 10.1111/jvh.12061
|
| 10 |
Edward N. Harris, Justin L. Mott. Molecules, Systems and Signaling in Liver Injury. 2017; doi: 10.1007/978-3-319-58106-4_1
|
| 11 |
Faezeh Ghasemi, Sina Rostami, Zahra Meshkat. Progress in the development of vaccines for hepatitis C virus infection. World Journal of Gastroenterology 2015; 21(42): 11984-12002 doi: 10.3748/wjg.v21.i42.11984
|
| 12 |
Jennifer M. Loftis. Animal Models of Neurological Conditions. 2026; doi: 10.1016/B978-0-443-29090-9.00006-4
|
| 13 |
Willemijn Hobo, Frans Maas, Niken Adisty, Theo de Witte, Nicolaas Schaap, Robbert van der Voort, Harry Dolstra. siRNA silencing of PD-L1 and PD-L2 on dendritic cells augments expansion and function of minor histocompatibility antigen–specific CD8+ T cells. Blood 2010; 116(22) doi: 10.1182/blood-2010-04-278739
|
| 14 |
Juan R. Larrubia, Selma Benito-Martínez, Joaquín Miquel, Miryam Calvino, Eduardo Sanz-de-Villalobos, Alejandro González-Praetorius, Sonia Albertos, Silvia García-Garzón, Megha Lokhande, Trinidad Parra-Cid. Bim-mediated apoptosis and PD-1/PD-L1 pathway impair reactivity of PD1+/CD127− HCV-specific CD8+ cells targeting the virus in chronic hepatitis C virus infection. Cellular Immunology 2011; 269(2) doi: 10.1016/j.cellimm.2011.03.011
|
| 15 |
Joseph M. Obeid, Paul R. Kunk, Victor M. Zaydfudim, Timothy N. Bullock, Craig L. Slingluff, Osama E. Rahma. Immunotherapy for hepatocellular carcinoma patients: is it ready for prime time?. Cancer Immunology, Immunotherapy 2018; 67(2) doi: 10.1007/s00262-017-2082-z
|
| 16 |
Maximilian Knapp, Christin Ackermann, Melanie Wittner, Claudia Beisel, Leon Cords, Tim Westphal, Liz Lam, Silke Kummer, Robin Woost, Sven Peine, Sven Pischke, Christoph Schultheiß, Ansgar W. Lohse, Andreas Walker, Jörg Timm, Mascha Binder, Julian Schulze zur Wiesch. CD96 marks a phenotypically distinct checkpoint-associated HCV-specific CD8+ T-cell subset featuring memory-associated states. Frontiers in Immunology 2026; 17 doi: 10.3389/fimmu.2026.1883007
|
| 17 |
Jessica Spahn, Robert H. Pierce, Ian N. Crispe. Ineffective CD8+ T-Cell Immunity to Adeno-Associated Virus Can Result in Prolonged Liver Injury and Fibrogenesis. The American Journal of Pathology 2011; 179(5) doi: 10.1016/j.ajpath.2011.08.004
|
| 18 |
Julia Nonnenmann, Renate Stirner, Julia Roider, Maria C. Jung, Kathrin Schrödl, Johannes R. Bogner, Rika Draenert, G. Silvestri. Lack of Significant Elevation of Myeloid-Derived Suppressor Cells in Peripheral Blood of Chronically Hepatitis C Virus-Infected Individuals. Journal of Virology 2014; 88(13) doi: 10.1128/JVI.00113-14
|